Back to search

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

NCT04070976

NAINTERVENTIONAL
National Institute of Cancerología
82 participants
Started 2019-07-01 · Completed 2024-12-30
Status: Unknown (as of 12-23-2025)

Conditions

Cervical Cancer

Linked Papers (from SciSciNet-V2)

Total Papers19
Background
4
Result
0
Derived
0
Unknown
15

Total Citations Per Year

Brief Summary

The main goal of this trial is to assess the safety and response rate to concomitant chemotherapy and external hypofractionated radiotherapy followed by brachytherapy in patients with clinical stage III cervical cancer. The trial will take place in the National Cancer Institute (INCan). Patients will be randomized into two groups: chemotherapy with external standard fractionated radiotherapy (45 Gy in 25 fractions) followed by brachytherapy or chemotherapy with external hypofractionated radiotherapy (37.5 Gy in 15 fractions) followed by brachytherapy.

Sort by:

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018
74,955 citations
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014
26,824 citations
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2018
6,648 citations
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999
2,214 citations
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
2019
876 citations
Cancer of the cervix uteri
2015
631 citations
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
2011
441 citations
A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer
2003
309 citations
Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial
2014
132 citations
NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care
2016
83 citations
Fractionated Grid Therapy in Treating Cervical Cancers: Conventional Fractionation or Hypofractionation?
2007
38 citations
Long‐term follow‐up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV‐negative women after conization
2015
22 citations
Hypofractionated radiotherapy in carcinoma cervix IIIB: Tata Memorial Hospital experience.
2003
17 citations
Disparities in Standard of Care Treatment and Associated Survival Decrement in Patients With Locally Advanced Cervical Cancer
2017
10 citations
Low-dose fractionated radiation and chemotherapy prior to definitive chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a prospective phase II clinical trial
2015
8 citations